• Submit Inquiry

New Drug Discovery Platform Based on Deep Phosphoproteomic Profiling

Lighting the Path to Precision Medicine.

About Kinase Insight
Kinase Insight pioneers a state-of-the-art drug discovery service platform, utilizing advanced equipment including Orbitrap Exploris 480 and Q Exactive Plus. Our mission is to deliver top-notch proteomic analysis services to a diverse range of pharmaceutical enterprises. With a specialized deep phosphoproteomic technology platform, coupled with proprietary methods and a robust bioinformatics platform, we offer comprehensive analyses covering total protein, total phosphorylation, and tyrosine phosphorylation. Our services provide efficient solutions for drug development and patient treatment, ensuring high-quality results and contributing to advancements in the field.
  • Targeted Protein Degradation (TPD) Omics Analysis Service
    Targeted analysis of TPD drugs based on DIA label-free quantitative proteomics.
    More
  • Tyrosine Phosphorylation Proteomics Analysis Service
    Hypothesis-free and direct analysis of TKI targeting capabilities within cells.
    More
Efficient and Comprehensive Solutions Based on Specialized Phosphoproteomics Platform
Covers three data dimensions: total protein, total phosphorylation, and tyrosine phosphorylation.
  • Neoantigen Sequencing Service
  • High-Throughput Antibody Screening Service
  • Oligo Mass Spectrometry Characterization
  • Macromolecule Drugs (mAb,ADC,AAV) Mass Spectrometry Characterization Service